Sai Parenteral's IPO Details:
| Company Name | Sai Parenteral's |
| Exchange | NSE, BSE |
| Share Price | ₹392 |
| Open Date | 24-March-2026 |
| Close Date | 27-March-2026 |
| List Date | 02-April-2026 |
| Face Value | 5 |
| Lot Size | 38 |
Sai Parenteral’s
We at SAI Parenteral’s Limited are a pharmaceutical company established with a clear purpose: to manufacture quality medicines with consistency, discipline, and long-term reliability. Over the years, we have evolved from a manufacturing-focused operation into a diversified formulations company that integrates research, development, and commercial-scale production.
Our business is organised around two complementary verticals. Through our branded generics portfolio, we serve a wide domestic market with established formulations across multiple therapeutic areas. In parallel, our Contract Development and Manufacturing Organisation (CDMO) services enable us to partner with pharmaceutical companies and support them across the product lifecycle, from development to commercial manufacturing.
for more visit website: Sai Parenteral’s
Sai Parenteral's IPO Financials
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 376.24 | 272.39 | 268.10 | 133.96 |
| Total Income | 89.43 | 163.74 | 155.18 | 97.03 |
| Profit After Tax | 7.76 | 14.43 | 8.42 | 4.38 |
| EBITDA | 16.24 | 39.44 | 31.70 | 17.64 |
| Net Worth | 209.37 | 95.78 | 76.40 | 31.49 |
| Reserves and Surplus | 188.84 | 80.36 | 61.30 | 24.34 |
| Total Borrowing | 76.07 | 93.95 | 118.79 | |
| Amount in ₹ Crore |
Allotment Information
| Just One Click Check Allotment Status |
| Visit Website Sai Parenteral's |